Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating non-coding RNAs as a diagnostic and management biomarker for breast cancer: current insights.

Molecular biology reports - 1 Jan 2022

Hosseinalizadeh Hamed, Mahmoodpour Mehrdad, Ebrahimi Ammar

Abstract excerpt

Cancer biomarkers can be used to determine the molecular status of a tumor or its metastases, which either release them directly into body fluids or indirectly through disruption of tumor/metastatic tissue. New minimally invasive and repeatable sample collection methods, such as liquid biopsy, have been developed in the last decade to apply cancer knowledge and track its progression. Circulating non-coding RNAs,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Breast Neoplasms
Share to Carcinogenesis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epigenesis, Genetic

Share to Liquid Biopsy

Share to Mutation

Share to RNA, Long Noncoding

Share to RNA, Small Interfering

Source

Identifiers

PMID: 34677714
DOI: 10.1007/s11033-021-06847-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating non-coding RNAs as a diagnostic and management biomarker for breast cancer: current insights.PMID 34677714Read ↗

The growing relevance of microRNAs as a diagnostic marker for breast cancerSemantic proximity Read ↗

Identification of Cell-Free Circulating MicroRNAs for the Detection of Early Breast Cancer and Molecular SubtypingSemantic proximity Read ↗

Long Noncoding RNAs as Novel Biomarkers Have a Promising Future in Cancer Diagnostics.Semantic proximity Read ↗

The applications of plasma cell-free DNA in cancer detection: Implications in the management of breast cancer patients.Semantic proximity Read ↗

Circulating Cell-Free DNA in Breast Cancer: Searching for Hidden Information towards Precision MedicineSemantic proximity Read ↗

Circulating circular RNA hsa_circ_0001785 acts as a diagnostic biomarker for breast cancer detectionSemantic proximity Read ↗

Circulating Tumor DNA in Breast Cancer: Current and Future Applications.Semantic proximity Read ↗

Precision Medicine for Breast Cancer Utilizing Circulating Tumor DNA: It Is in the Blood.Semantic proximity Read ↗

Circulating Tumor DNA Is a Variant of Liquid Biopsy with Predictive and Prognostic Clinical Value in Breast Cancer Patients.Semantic proximity Read ↗

Using Circulating MicroRNAs as Noninvasive Cancer Biomarkers in Breast Cancer is a Cutting-Edge Application of MicroRNA Profiling TechnologySemantic proximity Read ↗

Cell‐free circulating tumour DNA as a liquid biopsy in breast cancerSemantic proximity Read ↗

Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.